- P
Parthenon Therapeutics
- Antoine Italiano
Antoine Italiano is currently the Scientific Advisor at Parthenon Therapeutics. Prior to this, they were the Head of Precision Medicine at Gustave Roussy. Antoine has been in this role for 2 years and 4 months.
Antoine Italiano is a highly experienced and respected scientist in the field of precision medicine. Antoine has played a pivotal role in the development and implementation of precision medicine initiatives at Gustave Roussy. Their work has helped to improve the outcomes for cancer patients by providing them with more personalized and targeted treatment options.
Italiano is a strong advocate for the continued development of precision medicine, and they are passionate about helping to improve the lives of cancer patients. Antoine is an excellent communicator and has a deep understanding of the science behind precision medicine. Antoine is a trusted advisor to the Parthenon Therapeutics team and is committed to helping the company achieve its goal of becoming a world leader in precision medicine.
Antoine Italiano has a Université Bordeaux and a Université Nice Sophia Antipolis (membre d'Université Côte d'Azur). Antoine is a Docteur en médecine.
Org chart
This person is not in the org chart
Teams
Offices
This person is not in any offices
Parthenon Therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on rigorous, groundbreaking research, we are designing a portfolio of drug candidates to treat the right patients at the right time.
